ArticleBMJ open gastroenterology2025

Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot study.

Amera Elzubeir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.